Literature DB >> 23828392

Cutaneous venous malformations related to KRIT1 mutation: case report and literature review.

Francesca Romana Grippaudo1, Maria Piane, Matteo Amoroso, Benedetto Longo, Silvana Penco, Luciana Chessa, Maria Giubettini, Fabio Santanelli.   

Abstract

Cavernous malformations (CMs) are vascular anomalies of the nervous system mostly located in the brain. Cerebral cavernous malformations can present sporadically or familial, as a consequence of an autosomal dominant condition, with incomplete penetrance and variable clinical expression. Occasionally, extraneural manifestations of CMs involving the skin have been described. We report the case of two siblings presenting in adulthood diffuse cutaneous vascular lesions associated with cerebral CMs that, after surgical excision and histopathologic analysis, resulted to cavernous haemangiomas. Genomic DNA was extracted from peripheral blood, and molecular evaluation of KRIT1 gene was performed. Although no signs of neurological impairment were reported, cerebral MRI revealed multiple images in both patients, suggestive of cavernous haemangiomas. The genetic study demonstrated a nonsense mutation (c.535C>T) in the KRIT1 (Krev-1/rap1 interaction trapped 1) gene. Few reports describe extraneural manifestations of Cavernous malformation syndrome (CMs) related to a KRIT1 mutation; these involve the skin and are associated with hyperkeratotic cutaneous capillary-venous malformation. CMs should be suspected in patients developing multiple nodular cutaneous venous lesions in adulthood.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23828392     DOI: 10.1007/s12031-013-0053-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  21 in total

1.  Cavernous hemangiomatosis involving the brain, spinal cord, heart, skin and kidney: report of case.

Authors:  M W WOOD; R J WHITE; J W KERNOHAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1957-05-15

2.  Neurocutaneous vascular hamartomas mimicking Cobb syndrome. Case report.

Authors:  Y Wakabayashi; M Isono; T Shimomura; A Tajima; H Terashi; Y Asada; T Izumi; S Hori
Journal:  J Neurosurg       Date:  2000-07       Impact factor: 5.115

3.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

4.  Cerebral cavernous malformations. Incidence and familial occurrence.

Authors:  D Rigamonti; M N Hadley; B P Drayer; P C Johnson; K Hoenig-Rigamonti; J T Knight; R F Spetzler
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

5.  Cavernous hemangioma of the retina. A neuro-oculo-cutaneous syndrome.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1971-04       Impact factor: 5.258

6.  KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation.

Authors:  I Eerola; K H Plate; R Spiegel; L M Boon; J B Mulliken; M Vikkula
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

Review 7.  Genetics of cavernous angiomas.

Authors:  Pierre Labauge; Christian Denier; Francoise Bergametti; Elisabeth Tournier-Lasserve
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

8.  An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families.

Authors:  P Labauge; O Enjolras; J J Bonerandi; S Laberge; M Dandurand; J M Joujoux; E Tournier-Lasserve
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

9.  Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations.

Authors:  J Sirvente; O Enjolras; M Wassef; E Tournier-Lasserve; P Labauge
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-04-29       Impact factor: 6.166

10.  C329X in KRIT1 is a founder mutation among CCM patients in Sardinia.

Authors:  Milena Cau; Mario Loi; Maurizio Melis; Rita Congiu; Alberto Loi; Cristiana Meloni; Marianna Serrenti; Maria Addis; Maria Antonietta Melis
Journal:  Eur J Med Genet       Date:  2009-05-18       Impact factor: 2.708

View more
  6 in total

Review 1.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

Review 2.  CT and MRI of superficial solid tumors.

Authors:  Jingfeng Zhang; Yanyuan Li; Yilei Zhao; Jianjun Qiao
Journal:  Quant Imaging Med Surg       Date:  2018-03

Review 3.  Genetics of brain arteriovenous malformations and cerebral cavernous malformations.

Authors:  Hiroki Hongo; Satoru Miyawaki; Yu Teranishi; Daiichiro Ishigami; Kenta Ohara; Yu Sakai; Daisuke Shimada; Motoyuki Umekawa; Satoshi Koizumi; Hideaki Ono; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Hum Genet       Date:  2022-07-13       Impact factor: 3.755

4.  Familial Multiple Cavernous Malformation Syndrome: MR Features in This Uncommon but Silent Threat.

Authors:  Marc Mespreuve; Filip Vanhoenacker; Marc Lemmerling
Journal:  J Belg Soc Radiol       Date:  2016-03-21       Impact factor: 1.894

Review 5.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

6.  A novel CCM1 mutation associated with multiple cerebral and vertebral cavernous malformations.

Authors:  Silvia Lanfranconi; Dario Ronchi; Naghia Ahmed; Vittorio Civelli; Paola Basilico; Nereo Bresolin; Giacomo Pietro Comi; Stefania Corti
Journal:  BMC Neurol       Date:  2014-08-03       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.